Has Corporate Travel Management Ltd hit turbulence?

The share price of Corporate Travel Management Ltd (ASX:CTD) has dropped almost 30% – should investors be concerned?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After soaring above $13 in March, shares of Corporate Travel Management Ltd (ASX: CTD) have fallen almost 30% to trade around $9.50. Should investors be concerned?

Share price

Corporate Travel Management (CTM) reported earnings per share of $0.28 in the 2015 financial year (FY15). When its shares hit $13 it was trading on a price-to-earnings ratio (P/E) of 46 and many investors probably considered it was trading above its fair value.

If CTM doubles its earnings over the next 4 years and the shares are still trading at $9.50, it will trade on a P/E ratio of 17. The average P/E ratio of the ASX is currently 15.5 which provides some perspective of the growth expectations priced into the business.

CTM share price 3 years
Corporate Travel Management: 3-year chart. Source: Commsec

Over the past 3 years, CTM's share price has had a great run and long-term investors have enjoyed a 250% gain (even after the recent 30% fall).

Organic profit growth

Recently, the market has taken a dim view toward companies growing mainly by acquisition – such as childcare operator G8 Education Ltd (ASX: GEM) – and the market has wondered if the growth is sustainable.

Corporate Travel Management (CTM) is active in the acquisition market and added Travelcorp, Westminster Travel, USTravel, Avia International Travel, Chambers Travel and Diplomat Travel to the CTM group in the past 3 years.

The key difference that separates CTM from others like G8 Education is organic growth – the growth it achieves from building and improving its existing businesses, not the growth via acquisitions.

CTM's latest full year results presentation noted that more than 50% of the profit growth was organic. This is an impressive figure considering that group total transaction value (TTV) increased by 92% from $1.38 billion in FY14 to $2.66 billion in FY15.

Return on equity 

CTM is debt free (another important difference to the typical acquisitive business) which places it in a strong position to grow the business organically and to fund future acquisitions.

The return on equity (ROE = profit/equity) has been declining after the recent string of acquisitions where CTM is paying more – from a value perspective – to acquire these businesses compared to its organically grown earnings.

Why would it do this, you may ask? The acquisitions provided CTM an established brand and immediate access to the US, European and UK markets rather than trying to build up the business from scratch. This is worth the extra price if they prove to be valuable acquisitions.

For a simplified example, let's assume (these aren't CTM's actual figures) that during FY14 CTM used $50m equity to deliver a net profit of $10m. Therefore ROE (FY14) = $10m/$50m = 20%.

Now, during FY15 CTM acquired Chambers Travel for $50m but it will only contribute $5m in net profit. We now have the CTM ROE for FY15 = $15m / $100m = 15%. ROE has declined due to the acquisition.

Investors should monitor this metric as it will provide insight into the relative performance and integration of the acquisitions – ROE should increase as the new businesses are bedded down into the company and any synergies realised.

Foolish takeaway

CTM forecasts 25-30% growth in underlying earnings for FY16 and I expect it to continue growing quickly in the future. With no significant news coming from the company, it appears the recent sell-off is likely due to some profit taking.

The share price of a high-growth company trading at a premium to the market is often volatile, and a plummeting share price can cause people to question their investment thesis. However, volatility can be the long-term investor's best friend and provide an attractive entry point into a high-quality business like Corporate Travel Management.

Motley Fool contributor Mitch Sonogan owns shares of Corporate Travel Management Limited. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »